Role of corticotropin-releasing factor receptor-1 in opiate withdrawal

Journal of Neurochemistry

Volumn 74, Issue 1, 2000, Pages 199-208

  Iredale, Philip A ^b   Alvaro, John D ^b   Lee, Younglim ^b   Terwilliger, Rosemarie ^b   Chen, Yuhpyng L ^a   Duman, Ronald S ^b  

^a PFIZER INC   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amygdala; Corticotropin releasing factor antagonist; Morphine; Naltrexone; Nucleus accumbens; Striatum

Indexed keywords

BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MORPHINE; NALTREXONE; OPIATE; RECEPTOR SUBTYPE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG WITHDRAWAL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SCORING SYSTEM; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; PROTEIN ISOFORMS; PYRIMIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 0033970450     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0740199.x     Document Type: Article

References (49)

1. Ambrosio E., Sharpe L. G., and Pilotte N. S. (1997) Regional binding to corticotropin releasing factor receptors in brain of rats exposed to chronic cocaine and cocaine withdrawal. Synapse 25, 272-276.
2. Bianchetti A., Guidice A., Nava F., and Manara L. (1986) Dissociation of morphine withdrawal diarrhea and jumping in mice by the peripherally selective opioid antagonist SR 58002 C. Life Sci. 39, 2297-2303.
3. Brady L. S. (1994) Stress, antidepressant drugs and the locus coeruleus. Brain Res. Bull. 35, 545-556.
4. Brown M. R. and Fisher L. A. (1985) Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems. Fed. Proc. 44, 243-248.
5. Brugger S., Sanchez R., Brugger A. J., and Martinez J. A. (1998) ICV administration of CRF blocker (CRF9-41 δ helical) reduces morphine withdrawal in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 22, 775-785.
6. Chalmers D. T., Lovenberg T. W., and De Souza E. B. (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15, 6340-6350.
7. Chang C. P., Pearse R. V. II, O'Connell S., and Rosenfeld M. G. (1993) Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11, 1187-1195.
8. Chen R., Lewis K. A., Perrin M. H., and Vale W. W. (1993) Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. USA 90, 8967-8971.
9. Chen Y. L., Mansbach R. S., Winter S. M., Brooks E., Collins J., Corman M. L., Dunaiskis A. R., Faraci W. S., Gallaschun R. J., Schmidt A., and Schulz D. W. (1997) Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor 1 receptor antagonist. J. Med. Chem. 40, 1749-1754.
10. Duman R. S., Tallman J. F., and Nestler E. J. (1988) Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246, 1033-1039.
11. Eghbal-Ahmadi M., Hatalski C. G., Avishai-Eliner S., and Baram T. Z. (1997) Corticotophin releasing factor type II (CRF2) messenger RNA levels in the hypothalamic ventromedial nucleus of the infant rat are reduced by maternal deprivation. Endocrinology 139, 5048-5051.
12. Goeders N. E., Bienvenu O. J., and De Souza E. B. (1990) Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain. Brain Res. 531, 322-328.
13. Gold P. W., Goodwin F. K., and Chrousos G. P. (1988a) Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1). N. Engl. J. Med. 319, 348-353.
14. Gold P. W., Goodwin F. K., and Chrousos G. P. (1988b) Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2). N. Engl. J. Med. 319, 413-420.
15. Heinrichs S. C., Menzaghi F., Schulteis G., Koob G. F., and Stinus L. (1995) Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav: Pharmacol. 6, 74-80.
16. 1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex. J. Neurochem. 60, 1335-1343.
17. Hosoda K., Fitzgerald L. R., Vaidya V. A., Feussner G. K., Fishman P. H., and Duman R. S. (1995) Regulation of beta 2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition. Mol. Pharmacol. 48, 206-211.
18. Iredale P. A., Terwilliger R., Widnell K. L., Nestler E. J., and Duman R. S. (1996) Differential regulation of corticotropin releasing factor-1 receptor expression by stress and agonist treatments in brain and cultured cells. Mol. Pharmacol. 50, 1103-1110.
19. Iredale P. A., Bundey R., and Duman R. S. (1997) Phorbol ester and calcium regulation of corticotropin-releasing factor receptor-1 expression in a neuronal cell line. J. Neurochem. 69, 1912-1919.
20. Kishimoto T., Pearse R. V. II. Lin C. R., and Rosenfeld M. G. (1995) A sauvagine/corticotropin-releasing receptor expressed in heart and skeletal muscle. Prroc. Natl. Acad. Sci. USA 92, 1108-1112.
21. Koob G. F. and Bloom F. E. (19851 Corticotropin-releasing factor and behavior. Fed. Proc. 44, 259-263.
22. Lovenberg T. W., Liaw C. W., Grigoriadis D. E., Clevenger W., Chalmers D. T., De Souza E. B., and Oltersdorf T. (1995) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA 92, 836-840.
23. Lundkvist J., Teheranian R., Hasanvan H., Bartfai T., Jenck F., Widmer U., and Moreau J. L. (1996) A non peptide corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like effects. Eur. J. Pharmacol. 309, 195-200.
24. Maldonado R., Stinus L., Gold L. H., and Koob G. F. (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261, 669-677.
25. Mansbach R. S., Brooks E. N., and Chen Y. L. (1997) Antidepressant-like effects of CP-154,526, a selective CRF(1) receptor antagonist. Eur. J. Pharmacol. 323, 21-26.
26. Mansi J. A., Rivest S., and Drolet G. (1996) Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF. Endocrinology 137, 4619-4629.
27. Menzaghi F., Rassnick S., Heinrichs S., Baldwin H., Pich E. M., Weiss F., and Koob G. F. (1994) The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann. NY Acad. Sci. 739, 176-184.
28. Nemeroff C. B., Widerlov E., Bissette G., Walleus H., Karlson I., Eklund K., Kiilts C. D., Lossen P. T., and Vale W. W. (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226, 1342-1343.
29. Nemeroff C. B., Owens M. J., Bissette G., Andorn A. C., and Stanley M. (1988) Reduced corticotropin-releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry 45, 577-579.
30. Nestler E. J. (1996) Under siege: the brain on opiates. Neuron 16, 897-900.
31. Nibuya M., Nestler E. J., and Duman R. S. (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16, 2365-2372.
32. Owens M. J. and Nemeroff C. B. (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43, 425-473.
33. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., Sawchenko P., and Vale W. (1995) Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. USA 92, 2969-2973.
34. Pich E. M., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G. F., and Weiss F. (1995) Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15, 5439-5447.
35. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., Sawchenko P. E., and Vale W. (1994) Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad Sci. USA 91, 8777-8781.
36. Pozzoli G., Bilezikjian L. M., Perrin M. H., Blount A. L., and Vale W. W. (1996) Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology 137, 65-71.
37. Rasmussen K., Beitner-Johnson D., Krystal J. H., Aghajanian G. K., and Nestler E. J. (1990) Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10, 2308-2317.
38. Rasmussen K., Kendrick W. T., Kogan J. H., and Aghajanian G. K. (1996) A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropsychopharmacology 15, 497-505.
39. Rodriguez de Fonseca F. R., Carrera M. R. A., Navarro M., Koob G. F., and Weiss F. (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276, 2050-2054.
40. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., and Telegdy G. (1993) Alterations of corticotropin-releasing factor-like immuno-reactivity in different brain regions after acute cocaine administration in rats. Brain Res. 616, 315-319.
41. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., and Telegdy G. (1995) Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res. 675, 89-97.
42. Schulz D. W., Mansbach R. S., Sprouse J., Braselton J. P., Collins J., Corman M., Dunaiskis A., Faraci S., Schmidt A. W., Seeger T., Seymour P., Tingley D. F. III, Winston E. N., Chen Y. L., and Heym J. (1996) CP-154,526: a potent and selective non-peptide antagonist of corticotropin releasing factor receptors. Proc. Natl. Acad. Sci. USA 93, 10477-10482.
43. Shaham Y., Funk D., Erb S., Brown T. J., Walker C., and Stewart J. (1997) Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J. Neurosci. 17, 2605-2614.
44. 1 receptor attenuates stress-induced relapse to drug seeking in cocaine-and heroin-trained rats. Psychopharmacology (Berl.) 137, 184-190.
45. Terwilliger R. Z., Beitner-Johnson D., Sevarino K. A., Crain S. M., and Nestler E. J. (1991) A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548, 100-110.
46. Turnbull A. V. and Rivier C. (1997) Corticotropin-releasing factor (CRF) and endocrine responses to stress - CRF receptors, binding protein, and related peptides [Review]. Proc. Soc. Exp. Biol. Med. 215, 1-10.
47. Wei E. (1973) Assessment of precipitated abstinence in morphine-dependent rats. Psychopharmacologia 28, 35-44.
48. Zhou Y., Spangler R., LaForge K. S., Maggos C. E., Ho A., and Kreek M. J. (1996a) Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during binge-pattern cocaine administration and chronic withdrawal. J. Pharmacol. Exp. Ther. 279, 351-358.
49. Zhou Y., Spangler R., Maggos C. E., LaForge K. S., Ho A., and Kreek M. J. (1996b) Steady-state methadone in rats does not change mRNA levels of corticotropin-releasing factor, its pituitary receptor or proopiomelanocortin. Eur. J. Pharmacol. 315, 31-35.